Hologic Valuation Multiples

Hologic Overview

About Hologic

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Founded

1985

HQ

Employees

7.1K

Website

hologic.com

Sectors

Medical DevicesDiagnostics & GenomicsBioTechDeepTechLongevityFemTech

Financials (LTM)

Revenue: $4B

EBITDA: $1B

EV

$17B

Valuation Multiples

Multiples.vc

Start free trial

Hologic Financials

Hologic reported last 12-month revenue of $4B and EBITDA of $1B.

In the same LTM period, Hologic generated $2B in gross profit, $1B in EBITDA, and $980M in net income.

Hologic P&L

In the most recent fiscal year, Hologic reported revenue of $4B and EBITDA of $1B.

Hologic expects next 12-month revenue of XXX and NTM EBITDA of XXX

Hologic Stock Performance

Hologic has current market cap of $17B, and enterprise value of $17B.

Hologic's stock price is $75.44.

Hologic Valuation Multiples

Hologic trades at 4.1x EV/Revenue multiple, and 12.5x EV/EBITDA.

Hologic Financial Valuation Multiples

As of March 11, 2026, Hologic has market cap of $17B and EV of $17B.

Equity research analysts estimate Hologic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Hologic has a P/E ratio of 17.2x.

Hologic Margins & Growth Rates

Hologic's revenue in the last 12 month grew by 4%.

Hologic's revenue per employee in the last FY averaged $0.6M.

Hologic's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Hologic's rule of X is 42% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Hologic Public Comps

See public comps and valuation multiples for other Medical Devices and Diagnostics & Genomics comps.

Hologic M&A Activity

Hologic acquired XXX companies to date.

Last acquisition by Hologic was on XXXXXXXX, XXXXX. Hologic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Hologic Investment Activity

Hologic invested in XXX companies to date.

Hologic made its latest investment on XXXXXXXX, XXXXX. Hologic invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).